James G. Barbee, MD
- 3Articles
- 16.8KReads1
- 2002–2011Active
- 7Collaborators
- 62Citations2
About
James G. Barbee, MD, has published on the use of pharmacological augmentation strategies in treatment-resistant major depressive disorder. His work includes clinical trials evaluating lamotrigine and atypical antipsychotics such as olanzapine, risperidone, quetiapine, and ziprasidone as adjunctive treatments for unipolar depression. Barbee’s research, spanning from 2002 to 2011, focuses on therapeutic approaches for patients with refractory depression.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
